Adams, D., Algalarrondo, V
GLP-1 has also been shown to improve blood sugar control and reduce insulin resistance in those with type 2 diabetes who are overweight or obese
After helping patients organize their treatment routines, the pattern became clear: confusion breeds stop-start adherence, and stop-start adherence magnifies the drug's apparent cost because results slow and refills feel wasteful
Cornu M, Modi H, Kawamori D, Kulkarni RN, Joffraud M, Thorens B: Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression
For anyone with hypertension or cardiovascular risk, semaglutide is the safer choice by a wide margin